Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma

Abstract

Outcomes of LT have improved significantly, with contemporary survival now equivalent between these tumors and exceeding 80% 5-year OS. Future studies are needed to explore whether offering LT in patients that are resectable is justifiable.